Condition: Non-small Cell Lung Cancer Metastatic · Sponsor: Zealand University Hospital
The study is a prospective randomized interventional study including patients with advanced non-small cell lung cancer, receiving immunotherapy, with the aim of optimizing treatment monitoring. The study aims to investigate the clinical utility of liquid biopsy monitoring in order to reduce the numbers of inefficient treatments and needless toxicity - and to explore the cost-effectiveness and cost-utility of introducing liquid biopsy monitoring in daily clinical practice.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Department of Clinical Oncology | Hillerød, Region H, Denmark | Recruiting |
| Department of Clinical Oncology and Palliative Care | Næstved, Region Sjælland, Denmark | Recruiting |
| Department of Clinical Oncology and Palliative Care | Roskilde, Region Sjælland, Denmark | Recruiting |
| Department of Oncology | Aalborg, Denmark | Not Yet Recruiting |
| Department of Oncology | Vejle, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05889247